Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

por Chey, William D., Sayuk, Gregory S., Bartolini, Wilmin, Reasner, David S., Fox, Susan M., Bochenek, Wieslaw, Boinpally, Ramesh, Shea, Elizabeth, Tripp, Kenneth, Borgstein, Niels
Publicado 2021

Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study

por Brenner, Darren M., Argoff, Charles E., Fox, Susan M., Bochenek, Wieslaw, D'Astoli, Patricia, Blakesley, Rick E., Reasner, David S., O'Dea, Christopher R., Cash, Brooks D.
Publicado 2020

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

por Lacy, Brian E., Schey, Ron, Shiff, Steven J., Lavins, Bernard J., Fox, Susan M., Jia, Xinwei D., Blakesley, Rick E., Hao, Xinming, Cronin, Jacquelyn A., Currie, Mark G., Kurtz, Caroline B., Johnston, Jeffrey M., Lembo, Anthony J.
Publicado 2015

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

por Schoenfeld, Philip, Lacy, Brian E, Chey, William D, Lembo, Anthony J, Kurtz, Caroline B, Reasner, David S, Bochenek, Wieslaw, Tripp, Kenneth, Currie, Mark G, Fox, Susan M, Blakesley, Rick E, O’Dea, Christopher R, Omniewski, Nicholas D, Hall, Michael L
Publicado 2018

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

por Rao, Satish, Lembo, Anthony J, Shiff, Steven J, Lavins, Bernard J, Currie, Mark G, Jia, Xinwei D, Shi, Kelvin, MacDougall, James E, Shao, James Z, Eng, Paul, Fox, Susan M, Schneier, Harvey A, Kurtz, Caroline B, Johnston, Jeffrey M
Publicado 2012